Brochure | September 21, 2020

Solutions For Monoclonal Antibody Manufacturing

Source: Avantor
Monoclonal antibody MAB GettyImages-1294461540

Each stage of bioprocessing is influences by the steps preceding it. In the production of monoclonal antibodies (mAbs), manufacturing challenges such as reducing visibility, increasing yields, effective separation of impurities in downstream purification or achieving high protein concentration in formulation and drug product stability must be effectively managed in order to successfully complete regulatory review processes and bring new, life-altering medicines to the market.

As a trusted supplier for the top 20 biopharmaceutical companies, Avantor's expertise and solutions address the complexity of mAbs manufacturing. From process development and scale-up, through commercial manufacturing, we offer the products and support you need to help maintain mAbs quality, activity and stability throughout the entire process.

access the Brochure!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Bioprocess Online